BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25641762)

  • 1. Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling.
    Qiao F; Yao F; Chen L; Lu C; Ni Y; Fang W; Jin H
    Mol Carcinog; 2016 Mar; 55(3):280-91. PubMed ID: 25641762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
    Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
    J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
    Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
    Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    Wang P; Li L; Li T
    J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma.
    Fang WK; Liao LD; Li LY; Xie YM; Xu XE; Zhao WJ; Wu JY; Zhu MX; Wu ZY; Du ZP; Wu BL; Xie D; Guo MZ; Xu LY; Li EM
    J Pathol; 2013 Oct; 231(2):257-70. PubMed ID: 23836524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma.
    Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z
    Gene; 2017 May; 611():15-20. PubMed ID: 28119087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
    Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAB23, regulated by miR-92b, promotes the progression of esophageal squamous cell carcinoma.
    Cheng L; Yang F; Zhou B; Yang H; Yuan Y; Li X; Han S
    Gene; 2016 Dec; 595(1):31-38. PubMed ID: 27659550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
    Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
    Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
    Li Z; Jin H; Mao G; Wu L; Guo Q
    Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
    Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
    Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
    Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
    Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
    Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
    J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.